Search

everythinglearnresearchcommunity

for

Search:↓

Targeting specific T cells may help treat alopecia areata.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

Hair follicle stem cells prevent melanocyte stem cells from differentiating by controlling retinoic acid levels.

Blocking the CXCL12–CXCR4 axis may help treat hair loss in alopecia.

CD44 signaling can help heal wounds without scars.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Wnt-signaling is regulated differently in skin cells and immune responses during wound healing.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Blocking androgen receptors helps immune cells better fight certain bacteria.

c-Kit is important for heart regeneration and cancer development.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Nrf-2-modified stem cells from hair follicles significantly improve ulcerative colitis in rats.

Lack of functional CYLD in mice leads to early aging and cancer.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

AD-derived keratinocytes effectively mimic inflammation in atopic dermatitis.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.